Equities

Solventum Corp

Solventum Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)70.81
  • Today's Change1.18 / 1.69%
  • Shares traded700.08k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 21:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1946191
Total Receivables, Net1,3131,1711,177
Total Inventory857873813
Prepaid expenses------
Other current assets, total155126108
Total current assets2,5192,2312,189
Property, plant & equipment, net1,5551,4131,416
Goodwill, net6,5356,4346,666
Intangibles, net2,9023,2523,661
Long term investments------
Note receivable - long term------
Other long term assets432264143
Total assets13,94313,59414,075
LIABILITIES
Accounts payable477348320
Accrued expenses444260354
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total807703732
Total current liabilities1,7281,3111,406
Total long term debt000
Total debt000
Deferred income tax231215218
Minority interest------
Other liabilities, total318326392
Total liabilities2,2771,8522,016
SHAREHOLDERS EQUITY
Common stock------
Additional paid-in capital------
Retained earnings (accumulated deficit)------
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total11,66611,74212,059
Total equity11,66611,74212,059
Total liabilities & shareholders' equity13,94313,59414,075
Total common shares outstanding173173173
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.